Adient (NYSE:ADNT) Stock Price Expected to Rise, UBS Group Analyst Says

Adient (NYSE:ADNT) had its price objective lifted by equities researchers at UBS Group from $19.00 to $20.00 in a report issued on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s target price points to a potential upside of 9.58% from the stock’s current price.

A number of other research analysts also recently issued reports on ADNT. StockNews.com downgraded Adient from a “buy” rating to a “hold” rating in a report on Wednesday, January 22nd. JPMorgan Chase & Co. decreased their price target on Adient from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Monday. Wells Fargo & Company downgraded Adient from an “overweight” rating to an “equal weight” rating and decreased their price target for the company from $27.00 to $20.00 in a report on Monday, December 16th. Morgan Stanley decreased their price target on Adient from $21.00 to $19.00 and set an “underweight” rating for the company in a report on Thursday, November 14th. Finally, Bank of America cut Adient from a “buy” rating to a “neutral” rating and cut their price objective for the company from $30.00 to $24.00 in a research report on Thursday, November 21st. One analyst has rated the stock with a sell rating and nine have issued a hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $21.88.

Adient Trading Up 0.6 %

Adient stock opened at $18.25 on Wednesday. The company has a quick ratio of 0.90, a current ratio of 1.11 and a debt-to-equity ratio of 0.98. Adient has a 52 week low of $16.28 and a 52 week high of $36.04. The company has a market capitalization of $1.55 billion, a price-to-earnings ratio of 79.36, a price-to-earnings-growth ratio of 0.28 and a beta of 2.16. The stock has a 50-day moving average price of $18.00 and a 200 day moving average price of $20.59.

Adient (NYSE:ADNT) last released its earnings results on Tuesday, January 28th. The company reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.05). Adient had a return on equity of 6.86% and a net margin of 0.12%. During the same period last year, the company posted $0.31 EPS. Sell-side analysts anticipate that Adient will post 2.04 EPS for the current year.

Insider Buying and Selling

In other Adient news, EVP James Conklin sold 11,500 shares of the company’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $20.25, for a total transaction of $232,875.00. Following the sale, the executive vice president now owns 51,829 shares in the company, valued at $1,049,537.25. This represents a 18.16 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Versant Capital Management Inc lifted its position in Adient by 10,316.7% during the 4th quarter. Versant Capital Management Inc now owns 1,875 shares of the company’s stock worth $32,000 after acquiring an additional 1,857 shares during the period. R Squared Ltd acquired a new stake in shares of Adient in the 4th quarter valued at approximately $32,000. US Bancorp DE lifted its holdings in shares of Adient by 583.8% in the 3rd quarter. US Bancorp DE now owns 1,860 shares of the company’s stock valued at $42,000 after buying an additional 1,588 shares during the period. Signaturefd LLC lifted its holdings in shares of Adient by 493.8% in the 3rd quarter. Signaturefd LLC now owns 2,191 shares of the company’s stock valued at $49,000 after buying an additional 1,822 shares during the period. Finally, KBC Group NV lifted its holdings in shares of Adient by 51.8% in the 3rd quarter. KBC Group NV now owns 3,328 shares of the company’s stock valued at $75,000 after buying an additional 1,136 shares during the period. Hedge funds and other institutional investors own 92.44% of the company’s stock.

Adient Company Profile

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.